Major approaches and results of clinical studies of the connection gut microbiota-brain and the effects of nutrients and microorganisms in patients with schizophrenia: a systematic review and meta-analysis
Abstract
Introduction: Schizophrenia (SZ) affects approximately 20 million individuals worldwide. The gut microbiota (GM) plays a fundamental role. Objective: It was to present, through a meta-analysis, the main considerations and outcomes of clinical studies on the relationship between the gut microbiota-brain axis in patients with schizophrenia, as well as to highlight the effects of nutrients, prebiotics, and probiotics for the improvement of symptoms of schizophrenia. Methods: The PRISMA rules for meta-analysis were followed. The research was carried out from November 2024 to January 2025 in the Scopus, Embase, PubMed, Science Direct, and Scielo databases, using scientific articles from 2009 to 2024. The quality of the studies was based on the GRADE instrument and the risk of bias by the Cochrane (Funnel Plot). Results and Conclusion: It was founded 147 studies that underwent eligibility analysis. The final sample had 77 eligible studies and only 69 studies were described in the systematic review. Most studies showed homogeneity in their results, with I2 =15.7% <25%. The symmetrical funnel plot did not suggest a risk of bias among studies with small sample sizes. Altered gut microbiota composition was evidenced in people with obesity and chronic schizophrenia. The potential role of gut microbiota in schizophrenia is related to changes in brain structure and function. Intestinal serotonin production was potentially associated with an increased risk of schizophrenia. Furthermore,…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 20 participants or records.
Read the paper
Related studies
- Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale
- Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
- Exercise interventions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials
- Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
- Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.